Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
出版年份 2016 全文链接
标题
Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
作者
关键词
-
出版物
ONCOGENE
Volume 35, Issue 50, Pages 6403-6415
出版商
Springer Nature
发表日期
2016-06-06
DOI
10.1038/onc.2016.170
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation Sequencing
- (2014) R. Bourgon et al. CLINICAL CANCER RESEARCH
- Differences in DNA Methylation Signatures Reveal Multiple Pathways of Progression From Adenoma to Colorectal Cancer
- (2014) Yanxin Luo et al. GASTROENTEROLOGY
- Epiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastoma
- (2014) Shinji Kohsaka et al. NEURO-ONCOLOGY
- EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
- (2014) S. Rebouissou et al. Science Translational Medicine
- Epiregulin: Roles in normal physiology and cancer
- (2014) David J. Riese et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
- (2013) George Pentheroudakis et al. BMC CANCER
- High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor
- (2013) Gregor Auf et al. BMC CANCER
- Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
- (2013) D J Jonker et al. BRITISH JOURNAL OF CANCER
- Increased TGF- as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR-MET Interaction and Activation of MET Signaling in Colon Cancer Cells
- (2013) T. Troiani et al. CLINICAL CANCER RESEARCH
- Tumor fibroblast–derived epiregulin promotes growth of colitis-associated neoplasms through ERK
- (2013) Clemens Neufert et al. JOURNAL OF CLINICAL INVESTIGATION
- Epidermal Growth Factor Receptor Targeting in Head and Neck Cancer: Have We Been Just Skimming the Surface?
- (2013) Aaron R. Hansen et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia
- (2013) Daniel J. DeAngelo et al. LEUKEMIA RESEARCH
- S100A4 interacts with p53 in the nucleus and promotes p53 degradation
- (2013) L M Orre et al. ONCOGENE
- Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
- (2013) Yong-Liang Yao et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non-Small Cell Lung Cancer
- (2012) K. Walter et al. CLINICAL CANCER RESEARCH
- TGF-β1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis
- (2012) Victoria R. Skeen et al. CURRENT PHARMACEUTICAL DESIGN
- Role of NF-κB in epithelial biology
- (2012) Manolis Pasparakis IMMUNOLOGICAL REVIEWS
- Mutant KRAS Codon 12 and 13 Alleles in Patients With Metastatic Colorectal Cancer: Assessment As Prognostic and Predictive Biomarkers of Response to Panitumumab
- (2012) Marc Peeters et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers
- (2012) Jiyeon Yun et al. LABORATORY INVESTIGATION
- Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia
- (2012) E Lainey et al. ONCOGENE
- Molecular Genetics of Colorectal Cancer
- (2011) Eric R. Fearon Annual Review of Pathology-Mechanisms of Disease
- Epidermal growth factor receptor expression in acute myelogenous leukaemia is associated with clinical prognosis
- (2011) Jun-Zhong Sun et al. HEMATOLOGICAL ONCOLOGY
- Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines
- (2011) Goro Oshima et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Impact ofKRASandBRAFGene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer
- (2011) Timothy J. Price et al. JOURNAL OF CLINICAL ONCOLOGY
- 5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer
- (2010) Rodrigo Jover et al. GASTROENTEROLOGY
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- (2010) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma
- (2009) Gerusa G Seniski et al. BMC CANCER
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in EGFR Wild-type Cancers
- (2008) K. Yonesaka et al. CLINICAL CANCER RESEARCH
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
- (2008) Astrid Lièvre et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative lesion sequencing provides insights into tumor evolution
- (2008) S. Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More